Search clinical trials for: Clinically isolated syndrome (CIS)

Total 38985 results

Tianjin Medical University General Hospital
Shehzaad Joomye; Haiyun Wang; Donglai Yan

Unknown

Study of Cisatracurium and Sufentanil Consumption Using a Closed Loop Computer Control Infusion System

The Intraoperative Effect of Dexmedetomidine on Cisatracurium Infusion Consumption and Its Recovery Index. | Effect of Dexmedetomidine on Sufentanil Consumption. | Quantitative Analysis of Cisatracurium Infusion Requirements, Sufentanil Consumption and Recovery Index in Different Age...

China
University at Buffalo
University of Pavia

Completed

Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological Diseases

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Other Neurological Disorders (OND) | Healthy (HC)
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis (STAYCIS)

Multiple Sclerosis

United States, Canada
Roswell Park Cancer Institute

Recruiting

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Colorectal Cancer | Metastatic Unresectable Sarcoma | Metastatic Malignant Neoplasm in the Lung | Resectable Sarcoma | Metastatic Soft Tissue Sarcoma | Metastatic Bone Sarcoma

United States
Johns Hopkins University
National Institute of Mental Health (NIMH); University of Michigan

Recruiting

Clinic-based HIV Identification and Prevention Project Using Electronic Resources (CHIPPER)

PrEP | HIV Prevention | Primary Care

United States
Bayer

Completed

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study (PROmyBETAapp)

Multiple Sclerosis

Germany
Institute of Oncology Ljubljana

Unknown

IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment (BISER)

Rectal Carcinoma

Slovenia
Biogen

Completed

Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen (SFERA)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)

Czech Republic, Switzerland
Qmed Consulting A/S
Ambu A/S

Completed

Post Market Study to Collect Data for Software Recognizing the Anatomical Structures During Bronchoscopy.

Pulmonary Disease | Tumor | Hemoptysis

Denmark
Ambu A/S

Completed

AuraOnce Performance Observation

Anesthesia

Denmark
Ambu A/S

Completed

Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView

Anesthesia | Bronchoscopy

Germany
Ambu A/S

Terminated

Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting

Bronchoscopy | Atelectasis

United States
Firas Al-Ali
NYU Langone Health; Stryker Neurovascular; University of North Carolina, Chapel... and other collaborators

Completed

The Capillary Index Score Trial

Ischemic Stroke | Brain Ischemia | Acute Stroke

United States
Bayer

Completed

Physical Activity and Fatigue in Early Multiple Sclerosis (MS) (BEGIN)

Multiple Sclerosis

Switzerland, France, Germany, Indonesia, Korea, Republic of, Spain, Sweden, Thailand, Taiwan, Australia, Austria, Colombia, Czech Republic, Italy, Jordan, Kazakhstan, Lebanon, Mexico, Slovenia, United Kingdom, Bahrain, Egypt, United... and more
Hoffmann-La Roche
PPD; Laboratory Corporation of America; Illingworth Research Group

Active, not recruiting

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab (SOPRANINO)

Multiple Sclerosis | Clinically Isolated Syndrome

United States, Spain, United Kingdom, Germany
University Hospital, Lille

Unknown

Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS) (cinocis)

Multiple Sclerosis | Clinically Isolated Syndrome

France
University of Kansas

Withdrawn

Vitamin A, Its Receptors and Asthma

Asthma

United States
University Hospital, Brest

Recruiting

Development Cellular Models of the Ear and Nose to Study the Mechanisms of Hearing (CMAG)

Hearing Loss, GJB2, Cis Regulation, DFNB1

France
Seoul National University

Completed

Effect of Cis-9-cetylmyristoleate in Sub-healthy Subjects Presenting With Knee Joint Pain

Knee Pain Intermittent
Barmherzige Brüder Vienna

Completed

Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer

Bladder Cancer

Austria
Merck KGaA, Darmstadt, Germany
EMD Serono Canada Inc.

Completed

A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome (CIS-ON)

Clinically Isolated Syndrome

Canada
Memorial Sloan Kettering Cancer Center

Terminated

3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma

Neuroblastoma

United States
Memorial Sloan Kettering Cancer Center

Completed

3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow

Neuroblastoma

United States
University of Erlangen-Nürnberg Medical School
Deutsche Krebshilfe e.V., Bonn (Germany)

Terminated

Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer (Paccis-RCT)

Head and Neck Cancer

Germany
Roswell Park Cancer Institute

Completed

Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis

Stage IIIB Non-Small Cell Lung Cancer | Stage IV Non-Small Cell Lung Cancer | Stage IV Adult Soft Tissue Sarcoma | Metastatic Malignant Neoplasm in the Lung

United States
University Health Network, Toronto

Active, not recruiting

A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

Gallbladder Carcinoma | Biliary Tract Carcinoma

Canada
Memorial Sloan Kettering Cancer Center

Completed

3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma

Neuroblastoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva

Stage III Vulvar Cancer | Stage IVB Vulvar Cancer | Vulvar Squamous Cell Carcinoma

United States
APT Pharmaceuticals, Inc.

No longer available

Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients

Lung Transplant

United States
University of Copenhagen
Rigshospitalet, Denmark

Completed

The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS

Multiple Sclerosis | Clinically Isolated Syndrome | Optic Neuritis

Denmark
Memorial Sloan Kettering Cancer Center

Completed

High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation

Neuroblastoma

United States
Ambu Inc.
Ambu A/S

Completed

Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible Cystoscopy

Cystoscopy | Ureteral Stent

United States
Ambu A/S
Ambu Inc.; Infinite Clinical Solutions; Prelude Dynamics

Completed

A Single-Use Duodenoscope in a Real-World Setting

Endoscopic Retrograde Cholangiopancreatography (ERCP)

United States
Ambu A/S
QserveCRO

Completed

Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy

Lower Urinary Tract Symptoms | Bladder Disease | Cystoscope

Netherlands, Denmark
Ambu A/S

Completed

Study on Adhesion Properties of Three Different Adhesives

Healthy

Denmark
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Terminated

Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma

Metastatic Cholangiocarcinoma | Unresectable Cholangiocarcinoma | Advanced Cholangiocarcinoma

United States
Children's Hospital of Eastern Ontario
Canadian Institutes of Health Research (CIHR)

Completed

Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study (STOPP-CIS)

Acute Lymphoblastic Leukemia | Nephrotic Syndrome | Rheumatism

Canada
Endo Pharmaceuticals

Completed

Retrospective Chart Review of Valstar

Carcinoma in Situ of Bladder

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLC; University of Stellenbosch

Withdrawn

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

HIV Infection | Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | FIGO Stage IIB Cervix Carcinoma | FIGO Stage III Cervix Carcinoma | FIGO Stage IVA Cervix Carcinoma

South Africa, Zimbabwe
Teva Neuroscience, Inc.

Completed

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients (ENCORE)

Multiple Sclerosis
Dana-Farber Cancer Institute
Incyte Corporation

Active, not recruiting

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

Inflammatory Breast Cancer (IBC)

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Hypopharyngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma and other conditions

United States
Sirtex Medical

Completed

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma (SIRCCA)

Intrahepatic Cholangiocarcinoma

France, United Kingdom, Belgium, Australia, Spain, United States, Italy, Netherlands
Florida State University
Northwestern University

Completed

Training Language and Literacy for Children Who Use CIs

Hearing Loss, Sensorineural

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute; AstraZeneca; Sirtex Medical

Recruiting

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Cholangiocarcinoma | Bile Duct Cancer | Cholangiocarcinoma Non-resectable | Cholangiocarcinoma Metastatic | Metastatic Intrahepatic Cholangiocarcinoma

United States
Bayer

Completed

Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b (ADHERENCE)

Multiple Sclerosis
National Cancer Institute (NCI)

Terminated

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Laryngeal Verrucous Carcinoma | Recurrent Metastatic Squamous Cell Carcinoma in... and other conditions

Canada
NYU Langone Health

Completed

Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

Adult Solid Neoplasm

United States
Merck KGaA, Darmstadt, Germany
Merck Romania SRL, an affiliate of Merck KGaA, Darmstadt, Germany

Completed

Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™ (PROCEED)

Clinically Isolated Syndrome | Relapsing Multiple Sclerosis

Germany

Search clinical trials for: Clinically isolated syndrome (CIS)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations